Effect of paravertebral nerve block on post-operative cognitive function patients undergoing thoracic surgery

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000038201

Enrollment

Unknown

Registered

2020-09-13

Start date

2020-09-30

Completion date

Unknown

Last updated

2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

perioperative neurocognitive disorders

Interventions

experimental group:Subcutaneous analgesia group

Subcutaneous analgesia combine single paravertebral nerve block group

control group:Subcutaneous analgesia

Eligibility

Sex/Gender

All

Age

65 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Aged >= 65 years; 2. ASA grade II-III; 3. Elective surgery for lung and esophageal cancer.

Exclusion criteria

Exclusion criteria: 1. Preoperative cognitive impairment (MMSE score = 30 mg/d or other opioid equivalents); 4. History of drug allergy (opioid, local anesthetic, NSASIDs).

Design outcomes

Primary

Measure	Time frame
MMSE, MoCA cognitive function assessment scale score, ADL life activity ability score, subjective evaluation of family members and management doctors;	—

Countries

China

Contacts

Public ContactJin Gao

The First Affiliated Hospital of Chongqing Medical University

137777547@qq.com.+86 18523095418

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026